NCT01330784View on ClinicalTrials.gov

Assessment of the Therapeutic Utility of hMG-HP

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions
Sterility
Interventions
DRUG

hMG-HP

Trial Locations (1)

Unknown

Investigational site, Valencia

Sponsors
All Listed Sponsors
collaborator

Ferring SAU

INDUSTRY

lead

Ferring Pharmaceuticals

INDUSTRY

NCT01330784 - Assessment of the Therapeutic Utility of hMG-HP | Biotech Hunter | Biotech Hunter